These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 9774100)

  • 1. The ubiquitin pathway in Parkinson's disease.
    Leroy E; Boyer R; Auburger G; Leube B; Ulm G; Mezey E; Harta G; Brownstein MJ; Jonnalagada S; Chernova T; Dehejia A; Lavedan C; Gasser T; Steinbach PJ; Wilkinson KD; Polymeropoulos MH
    Nature; 1998 Oct; 395(6701):451-2. PubMed ID: 9774100
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
    Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K
    Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Ile93Met substitution in the UCH-L1 gene is not a disease-causing mutation for idiopathic Parkinson's disease.
    Shi Q; Tao E
    Chin Med J (Engl); 2003 Feb; 116(2):312-3. PubMed ID: 12775255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monogenic Parkinsonisms and the genetics of Parkinson's disease.
    Bonifati V
    Funct Neurol; 2001; 16(1):35-44. PubMed ID: 11396270
    [No Abstract]   [Full Text] [Related]  

  • 5. Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
    Leroy E; Boyer R; Polymeropoulos MH
    DNA Res; 1998 Dec; 5(6):397-400. PubMed ID: 10048490
    [No Abstract]   [Full Text] [Related]  

  • 6. Etiology of Parkinson's disease: Genetics and environment revisited.
    Steece-Collier K; Maries E; Kordower JH
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13972-4. PubMed ID: 12391311
    [No Abstract]   [Full Text] [Related]  

  • 7. cDNA cloning and tissue distribution of a rat ubiquitin carboxyl-terminal hydrolase PGP9.5.
    Kajimoto Y; Hashimoto T; Shirai Y; Nishino N; Kuno T; Tanaka C
    J Biochem; 1992 Jul; 112(1):28-32. PubMed ID: 1331034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.
    Larsen CN; Krantz BA; Wilkinson KD
    Biochemistry; 1998 Mar; 37(10):3358-68. PubMed ID: 9521656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the specificity of ubiquitin C-terminal hydrolases.
    Johnston SC; Riddle SM; Cohen RE; Hill CP
    EMBO J; 1999 Jul; 18(14):3877-87. PubMed ID: 10406793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and analysis of expression of a ubiquitin carboxyl terminal hydrolase expressed during oogenesis in Drosophila melanogaster.
    Zhang N; Wilkinson K; Bownes M
    Dev Biol; 1993 May; 157(1):214-23. PubMed ID: 7683284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of Parkinson's disease.
    de Silva HR; Khan NL; Wood NW
    Curr Opin Genet Dev; 2000 Jun; 10(3):292-8. PubMed ID: 10826990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.
    Maraganore DM; Farrer MJ; Hardy JA; Lincoln SJ; McDonnell SK; Rocca WA
    Neurology; 1999 Nov; 53(8):1858-60. PubMed ID: 10563640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes.
    Wilkinson KD
    FASEB J; 1997 Dec; 11(14):1245-56. PubMed ID: 9409543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadzooks!
    MacDonald ME
    Nat Genet; 1999 Sep; 23(1):10-1. PubMed ID: 10471487
    [No Abstract]   [Full Text] [Related]  

  • 15. Cleavage of the C-terminus of NEDD8 by UCH-L3.
    Wada H; Kito K; Caskey LS; Yeh ET; Kamitani T
    Biochem Biophys Res Commun; 1998 Oct; 251(3):688-92. PubMed ID: 9790970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.
    Harhangi BS; Farrer MJ; Lincoln S; Bonifati V; Meco G; De Michele G; Brice A; Dürr A; Martinez M; Gasser T; Bereznai B; Vaughan JR; Wood NW; Hardy J; Oostra BA; Breteler MM
    Neurosci Lett; 1999 Jul; 270(1):1-4. PubMed ID: 10454131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.
    Lincoln S; Vaughan J; Wood N; Baker M; Adamson J; Gwinn-Hardy K; Lynch T; Hardy J; Farrer M
    Neuroreport; 1999 Feb; 10(2):427-9. PubMed ID: 10203348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pseudogene for a novel ubiquitin C-terminal hydrolase of S. cerevisiae.
    Jentsch S
    Nucleic Acids Res; 1991 Mar; 19(5):1147. PubMed ID: 1826949
    [No Abstract]   [Full Text] [Related]  

  • 19. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.
    Momose Y; Murata M; Kobayashi K; Tachikawa M; Nakabayashi Y; Kanazawa I; Toda T
    Ann Neurol; 2002 Jan; 51(1):133-6. PubMed ID: 11782995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequence comparison between human and marsupial genes encoding PGP9.5--a neurone-specific ubiquitin C-terminal hydrolase.
    Lavender FL; Day IN; Thompson RJ
    Biochem Soc Trans; 1992 Aug; 20(3):263S. PubMed ID: 1426554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.